Aeglea BioTherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.75
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.23
|
-0.19
|
0.04
|
17.39%
|
|
2022-06-30
|
-0.31
|
-0.27
|
0.04
|
12.90%
|
|
2022-03-31
|
-0.34
|
-0.37
|
-0.03
|
-8.82%
|
|
2021-12-31
|
-0.29
|
-0.31
|
-0.02
|
-6.90%
|
|
2021-09-30
|
-0.28
|
-0.31
|
-0.03
|
-10.71%
|
|
2021-06-30
|
-0.16
|
-0.10
|
0.06
|
37.50%
|
|
2021-03-31
|
-0.17
|
-0.28
|
-0.11
|
-64.71%
|
|
2020-12-31
|
-0.31
|
-0.35
|
-0.04
|
-12.90%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.83
|
|
2021-12-31
|
-1.00
|
|
2020-12-31
|
-1.61
|
|
2019-12-31
|
-2.45
|
|
2018-12-31
|
-2.11
|
|
2017-12-31
|
-1.80
|
|
2016-12-31
|
-8.59
|